Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations AFY Al Hadithy, NKH De Boer, LJJ Derijks, JC Escher, CJJ Mulder, ... Digestive and liver disease 37 (4), 282-297, 2005 | 143 | 2005 |
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia AFY Al Hadithy, SA Ivanova, P Pechlivanoglou, A Semke, O Fedorenko, ... Progress in neuro-psychopharmacology and biological psychiatry 33 (3), 475-481, 2009 | 108 | 2009 |
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia SA Ivanova, AJM Loonen, P Pechlivanoglou, MB Freidin, AFY Al Hadithy, ... Translational Psychiatry 2 (1), e67-e67, 2012 | 103 | 2012 |
Protein transduction domains and their utility in gene therapy AMJ Beerens, AFY Al Hadithy, MG Rots, HJ Haisma Current gene therapy 3 (5), 486-494, 2003 | 85 | 2003 |
Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes J Vehof, H Burger, B Wilffert, A Al Hadithy, BZ Alizadeh, H Snieder European Neuropsychopharmacology 22 (9), 625-631, 2012 | 79 | 2012 |
Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication J Vehof, AJ Risselada, AFY Al Hadithy, H Burger, H Snieder, B Wilffert, ... Psychopharmacology 216, 257-265, 2011 | 74 | 2011 |
Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study AJ Risselada, J Vehof, R Bruggeman, B Wilffert, D Cohen, AF Al Hadithy, ... The Pharmacogenomics Journal 12 (1), 62-67, 2012 | 71 | 2012 |
Missense polymorphisms in three oxidative‐stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia AFY Al Hadithy, SA Ivanova, P Pechlivanoglou, B Wilffert, A Semke, ... Human Psychopharmacology: Clinical and Experimental 25 (1), 84-91, 2010 | 69 | 2010 |
Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder KP Grootens, A Meijer, EG Hartong, B Doornbos, PR Bakker, A Al Hadithy, ... European journal of clinical pharmacology 74, 1485-1489, 2018 | 64 | 2018 |
The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic … B Wilffert, AFY Al Hadithy, VJ Sing, G Matroos, HW Hoek, J Van Os, ... Journal of Psychopharmacology 23 (6), 652-659, 2009 | 54 | 2009 |
Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinic GP Hooff, RJW Meesters, JJA van Kampen, NA van Huizen, B Koch, ... Analytical and bioanalytical chemistry 400, 3473-3479, 2011 | 43 | 2011 |
Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African‐Caribbean inpatients: Differences in association with dopamine and serotonin receptors AF Al Hadithy, B Wilffert, RE Stewart, NM Looman, R Bruggeman, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147 …, 2008 | 41 | 2008 |
Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients JP Koning, J Vehof, H Burger, B Wilffert, A Al Hadithy, B Alizadeh, ... Psychopharmacology 219, 727-736, 2012 | 36 | 2012 |
Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women M Naunton, AFY Al Hadithy, JRBJ Brouwers, DF Archer Menopause 13 (3), 517-527, 2006 | 34 | 2006 |
Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study PR Bakker, AFY Al Hadithy, N Amin, CM Van Duijn, J Van Os, ... PLoS One 7 (12), e50970, 2012 | 33 | 2012 |
Lack of association between antipsychotic‐induced Parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African‐Caribbeans and the possible role of the medication: The … AF Al Hadithy, B Wilffert, R Bruggeman, RE Stewart, JR Brouwers, ... Human Psychopharmacology: Clinical and Experimental 24 (2), 123-128, 2009 | 30 | 2009 |
Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient … SA Ivanova, AJM Loonen, PR Bakker, MB Freidin, NJ Ter Woerds, ... SAGE Open Medicine 4, 2050312116643673, 2016 | 25 | 2016 |
No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia SA Ivanova, AFY Al Hadithy, N Brazovskaya, A Semke, B Wilffert, ... Human Psychopharmacology: Clinical and Experimental 27 (3), 334-337, 2012 | 24 | 2012 |
Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia SA Ivanova, LM Geers, AFY Al Hadithy, P Pechlivanoglou, AV Semke, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 50, 172-177, 2014 | 21 | 2014 |
Genetic Risk and Outcome in Psychosis (GROUP) investigators. Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young … JP Koning, J Vehof, H Burger, B Wilffert, A Al Hadithy, B Alizadeh, ... Psychopharmacology (Berl) 219 (3), 727-736, 2012 | 21 | 2012 |